Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis

Weekly rifapentine and isoniazid therapy (3HP) is the most frequent treatment for latent tuberculosis infection (LTBI). However, the association between major adverse drug reactions (ADRs) and drug metabolic enzyme single-nucleotide polymorphisms (SNPs) remains unclear. In this study, 377 participan...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Environ Res Public Health
Main Authors: Yu, Ya-Yen, Tsao, Shih-Ming, Yang, Wen-Ta, Huang, Wei-Chang, Lin, Ching-Hsiung, Chen, Wei-Wen, Yang, Shun-Fa, Chiou, Hui-Ling, Huang, Yi-Wen
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6981901/
https://ncbi.nlm.nih.gov/pubmed/31892222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph17010210
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares